February Session, 2018
LCO No. 5020
SEN. LEONE, 27th Dist.
SEN. WITKOS, 8th Dist.
REP. D'AGOSTINO, 91st Dist.
REP. ARCONTI, 109th Dist.
REP. SMITH, 108th Dist.
"AN ACT CONCERNING BIOLOGICAL PRODUCTS."
In line 63, strike "forty-eight" and substitute "seventy-two" in lieu thereof
In line 69, strike "forty-eight" and substitute "seventy-two" in lieu thereof
Strike lines 176 to 185, inclusive, in their entirety
In line 186, strike "(p)" and insert "(n)" in lieu thereof
In line 189, insert "(a)" before "Prior"
In line 194, after "product.", insert "The prescribing practitioner shall inform the patient that he or she may opt to sign for delivery of the biological product."
In line 196, after "place", insert "This section shall not apply to hospital inpatients, emergency care, F.D.A. approved vaccines, blood or blood components."
After line 196, insert the following:
"(b) The patient or a representative of the patient may make a request of the pharmacy that the patient or representative be present to sign for delivery of the interchangeable biological product. The patient or representative of the patient may rescind such request at any time by notifying the pharmacy of such rescission."